Roshni Sundaram, Ph.D.
Affiliations: | 2003 | Ohio State University, Columbus, Columbus, OH |
Area:
Microbiology Biology, Oncology, ImmunologyGoogle:
"Roshni Sundaram"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Pravin Kaumaya | grad student | 2003 | Ohio State | |
| (Evaluation of T-cell and B -cell epitopes and design of multivalent vaccines against HTLV-1 diseases.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Dakappagari NK, Sundaram R, Rawale S, et al. (2005) Intracellular delivery of a novel multiepitope peptide vaccine by an amphipathic peptide carrier enhances cytotoxic T-cell responses in HLA-A*201 mice. The Journal of Peptide Research : Official Journal of the American Peptide Society. 65: 189-99 |
| Sundaram R, Lynch MP, Rawale S, et al. (2004) Protective efficacy of multiepitope human leukocyte antigen-A*0201 restricted cytotoxic T-lymphocyte peptide construct against challenge with human T-cell lymphotropic virus type 1 Tax recombinant vaccinia virus. Journal of Acquired Immune Deficiency Syndromes (1999). 37: 1329-39 |
| Sundaram R, Lynch MP, Rawale SV, et al. (2004) De novo design of peptide immunogens that mimic the coiled coil region of human T-cell leukemia virus type-1 glycoprotein 21 transmembrane subunit for induction of native protein reactive neutralizing antibodies. The Journal of Biological Chemistry. 279: 24141-51 |
| Sundaram R, Beebe M, Kaumaya PT. (2004) Structural and immunogenicity analysis of chimeric B-cell epitope constructs derived from the gp46 and gp21 subunits of the envelope glycoproteins of HTLV-1. The Journal of Peptide Research : Official Journal of the American Peptide Society. 63: 132-40 |
| Sundaram R, Sun Y, Walker CM, et al. (2003) A novel multivalent human CTL peptide construct elicits robust cellular immune responses in HLA-A*0201 transgenic mice: implications for HTLV-1 vaccine design. Vaccine. 21: 2767-81 |
| Sundaram R, Dakappagari NK, Kaumaya PT. (2002) Synthetic peptides as cancer vaccines. Biopolymers. 66: 200-16 |